The survival analysis performed in this study also showed endometrial cancer patients with rare variants in NDUFB6 have a significantly lower survival rate than endometrial cancer patients with no rare variants reemphasizing its possible role in endometrial cancer. Here, NDUFB6 is linked to endometrial cancer.